Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124433582 | 12443358 | 2 | F | 201605 | 20160622 | 20160607 | 20160705 | EXP | US-GLAXOSMITHKLINE-US2016072650 | GLAXOSMITHKLINE | 54.29 | YR | F | Y | 69.84000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124433582 | 12443358 | 1 | PS | NUCALA | MEPOLIZUMAB | 1 | Subcutaneous | 100 MG, U | 2415 | 125526 | 100 | MG | POWDER FOR INJECTION | ||||||
| 124433582 | 12443358 | 2 | SS | ALBUTEROL. | ALBUTEROL | 1 | 2 PUFF(S), EVERY TWO MINUTES | U | 0 | 2 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124433582 | 12443358 | 1 | Asthma |
| 124433582 | 12443358 | 2 | Dyspnoea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124433582 | 12443358 | Asthma | |
| 124433582 | 12443358 | Drug ineffective | |
| 124433582 | 12443358 | Dyspnoea | |
| 124433582 | 12443358 | Emergency care | |
| 124433582 | 12443358 | Inappropriate schedule of drug administration | |
| 124433582 | 12443358 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124433582 | 12443358 | 1 | 201605 | 0 |